Arama Sonuçları - Jin-liang Kong

SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer Yazar: Wei Hou, Guo-Sheng Li, Li Gao, Hui-Ping Lu, Hua-Fu Zhou, Jin-Liang Kong, Gang Chen, Shuang Xia, Hong-Yu Wei

Connect to this object online.

MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip Yazar: Li Gao, Shi-bai Yan, Jie Yang, Jin-liang Kong, Ke Shi, Fu-chao Ma, Lin-zhen Huang, Jie Luo, Shu-ya Yin, Rong-quan He, Xiao-hua Hu, Gang Chen

Connect to this object online.